These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6605119)

  • 41. Serum procalcitonin levels in patients with ankylosing spondylitis.
    Ozmen M; Oktay E; Tarhan EF; Aslan O; Oflazoglu U; Koseoglu MH
    Int J Rheum Dis; 2016 May; 19(5):500-5. PubMed ID: 24798190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunoglobulins and acute-phase proteins in ankylosing spondylitis].
    Warneboldt J; Vorlaender KO; Erel U; Oezer H
    Verh Dtsch Ges Rheumatol; 1978; 5():140-1. PubMed ID: 309229
    [No Abstract]   [Full Text] [Related]  

  • 43. Aerobic capacity and its correlates in patients with ankylosing spondylitis.
    Hsieh LF; Wei JC; Lee HY; Chuang CC; Jiang JS; Chang KC
    Int J Rheum Dis; 2016 May; 19(5):490-9. PubMed ID: 24754841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of IL-2 and IL-11 and its significance in patients with ankylosing spondylitis.
    Liu F; Wang F; Wang CC; Li N; Li SF
    Asian Pac J Trop Med; 2013 Jan; 6(1):76-8. PubMed ID: 23317891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review.
    Ruof J; Stucki G
    J Rheumatol; 1999 Apr; 26(4):966-70. PubMed ID: 10229429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fetuin-A and interleukin-18 levels in ankylosing spondylitis.
    Sari I; Kebapcilar L; Taylan A; Bilgir O; Kozaci DL; Yildiz Y; Yuksel A; Gunay N; Akkoc N
    Int J Rheum Dis; 2010 Feb; 13(1):75-81. PubMed ID: 20374388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
    Xie J; Yu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.
    Park MC; Lee SW; Choi ST; Park YB; Lee SK
    Scand J Rheumatol; 2007; 36(2):101-6. PubMed ID: 17476615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients.
    Borawski J; Myśliwiec M
    Nephron; 2001 Dec; 89(4):381-3. PubMed ID: 11721153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of balneotherapy on the reactants of acute inflammation phase in ankylosing spondylitis].
    Srp Arh Celok Lek; 2009; 137(5-6):255-8. PubMed ID: 19594066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Erythrocyte sedimentation rate and serum immunoglobulins in rheumatic pelvispondylitis].
    Dougados M; Gaudouen Y; Blan M; Boumier P; Raichvarg D; Amor B
    Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):273-8. PubMed ID: 3589456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.
    Dixon JS; Bird HA; Wright V
    Ann Rheum Dis; 1981 Aug; 40(4):404-8. PubMed ID: 7259332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis.
    Yildirim K; Erdal A; Karatay S; Melikoğlu MA; Uğur M; Senel K
    South Med J; 2004 Apr; 97(4):350-3. PubMed ID: 15108827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunoglobulins and complement components in human aortic atherosclerotic intima.
    Vlaicu R; Rus HG; Niculescu F; Cristea A
    Atherosclerosis; 1985 Apr; 55(1):35-50. PubMed ID: 2408631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgG myeloma).
    Wiedermann D; Widermann B; Cídl K; Kodousková V
    Neoplasma; 1978; 25(2):189-96. PubMed ID: 643123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.
    Trull A; Ebringer A; Panayi G; Ebringer R; James DC
    Clin Exp Immunol; 1984 Jan; 55(1):74-80. PubMed ID: 6607143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
    Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
    Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.